Komori
Financial results presentation286AEUCALIA Inc.Information and Communications, Services and Others

Financial Results Presentation for the Second Quarter of the Fiscal Year Ending December 2026

First-half revenue increased, driven by growth in existing businesses and the effects of M&A completed in the previous fiscal year, while profit declined due to the reversal of one-time income recognized in the previous fiscal year and strategic investments. The number of newly acquired partner hospitals fell short of plan, but BPO and home healthcare progressed above or in line with plan, and the full-year earnings forecast was maintained.

Worth reading
53Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
-739
¥ million (year-on-year change in operating income)
Wording
Conditional
How definitive the wording is.

Contents of this document

Financial results presentationSecond quarter of the fiscal year ending December 202610 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥13,678 million+30.0%
Operating profit¥395 million-65.0%
Net income¥489 million-40.0%
Gross Profit Margin38.4 %
Operating profit margin2.8 %
Results for the three months of the current quarter
Net Sales
¥7,193 million
Gross profit
¥2,789 million
Operating profit
¥320 million
Profit attributable to owners of the parent
¥119 million
Full-year earnings forecast
Net Sales
¥33,035 million
Gross profit
¥13,509 million
Operating profit
¥2,864 million
EBITDA
¥4,502 million
Profit attributable to owners of the parent
¥1,658 million
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
Progress is in line with expectations versus the initial plan
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
Net Sales
Comprehensive medical management support410
Senior-related services601
Highly controlled medical devices280
Other102
Increment from M&A in FY2025 December1,765
Profit attributable to owners of the parent
Incremental profit from higher revenue611
Goodwill amortization and PMI costs-125
Strategic Investment-525
Reversal of one-time income-700
Extraordinary gains and losses-339
Non-operating income and expenses120
Tax effects, etc.233
New initiatives
  • Initiation of external and full-scale rollout of financial services
  • Launch of a trial of financial services for medical institutions
Key KPIsA metric the company considers important as a management benchmark.
  • Number of affiliated hospitals29 Engagements
    Year on year against the same period last year-2.0%
  • Number of homes operated12 homes
  • Occupancy rate of existing homes92.8 %
  • Occupancy rate of new homes94.7 %
  • Number of placement referrals4,210 Engagements
    Year on year against the same period last year-0.8%
  • Number of hospitals using BPO services6 Hospitals
  • Increase in home healthcare users3,100 people
Segment results
Comprehensive medical management support
Net Sales
¥5,058 million
Year-on-Year Change in Revenue (%)65
Operating profit
¥456 million
Operating profit year-on-year_pct-64
Senior-related services
Net Sales
¥4,427 million
Year-on-Year Change in Revenue (%)19
Operating profit
¥311 million
Operating profit year-on-year_pct66
Highly controlled medical devices
Net Sales
¥3,832 million
Year-on-Year Change in Revenue (%)7
Operating profit
¥240 million
Operating profit year-on-year_pct-13
Other
Net Sales
¥376 million
Year-on-Year Change in Revenue (%)71
Operating profit
¥117 million
Operating profit year-on-year_pct186
Financial targets
Equity ratio
End of December 202531.5 %
End of June 202631.2 %
Market Size / Share
Number of medical facilities
114,000 Facility
Breakdown
Hospitals
8,000 Hospitals
clinics
106,000 clinics
Number of stores and locations
New home healthcare locations opened2 branch offices
Operating margin (second quarter only)
4.4 %
Gross profit margin (second quarter only)
38.7 %
Contents of this document
ItemDetails
Document typeFinancial results presentation
Fiscal Period CoveredSecond quarter of the fiscal year ending December 2026
Net Sales¥13,678 million (YoY +30.0%)
Operating profit¥395 million (YoY -65.0%)
Net income¥489 million (YoY -40.0%)
Gross Profit Margin38.4 %
Operating profit margin2.8 %
Results for the three months of the current quarterNet Sales ¥7,193 million / Gross profit ¥2,789 million / Operating profit ¥320 million / Profit attributable to owners of the parent ¥119 million
Full-year earnings forecastNet Sales ¥33,035 million / Gross profit ¥13,509 million / Operating profit ¥2,864 million / EBITDA ¥4,502 million / Profit attributable to owners of the parent ¥1,658 million
Self-assessment against the planProgress is in line with expectations versus the initial plan
Segment resultsComprehensive medical management support Net Sales ¥5,058 million / Year-on-Year Change in Revenue (%) 65 / Operating profit ¥456 million / Operating profit year-on-year_pct -64 / Senior-related services Net Sales ¥4,427 million / Year-on-Year Change in Revenue (%) 19 / Operating profit ¥311 million / Operating profit year-on-year_pct 66 / Highly controlled medical devices Net Sales ¥3,832 million / Year-on-Year Change in Revenue (%) 7 / Operating profit ¥240 million / Operating profit year-on-year_pct -13 / Other Net Sales ¥376 million / Year-on-Year Change in Revenue (%) 71 / Operating profit ¥117 million / Operating profit year-on-year_pct 186
Breakdown of Factors Affecting the ChangeNet Sales Comprehensive medical management support 410 / Senior-related services 601 / Highly controlled medical devices 280 / Other 102 / Increment from M&A in FY2025 December 1,765 / Profit attributable to owners of the parent Incremental profit from higher revenue 611 / Goodwill amortization and PMI costs -125 / Strategic Investment -525 / Reversal of one-time income -700 / Extraordinary gains and losses -339 / Non-operating income and expenses 120 / Tax effects, etc. 233
Key KPIsIndicator name Number of affiliated hospitals / Value 29 Engagements / Year on year against the same period last year -2 Engagements, Indicator name Number of homes operated / Value 12 homes / Year on year against the same period last year Not disclosed, Indicator name Occupancy rate of existing homes / Value 92.8 % / Year on year against the same period last year Not disclosed, Indicator name Occupancy rate of new homes / Value 94.7 % / Year on year against the same period last year Not disclosed, Indicator name Number of placement referrals / Value 4,210 Engagements / Year on year against the same period last year -0.8 Engagements, Indicator name Number of hospitals using BPO services / Value 6 Hospitals / Year on year against the same period last year Not disclosed, Indicator name Increase in home healthcare users / Value 3,100 people / Year on year against the same period last year Not disclosed
Number of stores and locationsNew home healthcare locations opened 2 branch offices
Financial targetsEquity ratio End of December 2025 31.5 % / End of June 2026 31.2 %
Market Size / ShareNumber of medical facilities 114,000 Facility / Breakdown Hospitals 8,000 Hospitals / clinics 106,000 clinics
New initiativesInitiation of external and full-scale rollout of financial services, Launch of a trial of financial services for medical institutions
Operating margin (second quarter only)4.4 %
Gross profit margin (second quarter only)38.7 %
Items this document does not state (14)
Ordinary incomeSelling, general and administrative expensesProgress against full-year forecastUnit price and quantity metricsNumber of employeesAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookMedium-term management plan targetsAnnual DividendPayout ratioAcquisition of treasury sharesCapital expendituresOrders received and order backlogKey points of the Q&A

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Revenue increased due to growth in existing businesses and the contribution from M&A completed in the previous fiscal year. Profit was adversely affected by the reversal of one-time income recognized in the previous fiscal year, strategic investments including costs related to Hippocratic AI, and goodwill amortization and PMI expenses. Medical management support fell short of budget because of delays in acquiring new partner hospitals, while BPO and home healthcare grew.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Financial Results Presentation for the Second Quarter of the Fiscal Year Ending December 2026 | EUCALIA Inc. (286A) timely disclosure | Komori